IQVIA RDS Inc.
IQVIA RDS Inc.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not applicable | 2026-10-09 | NCT07867886 | |
| A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of Care | Bacterial Infections and Mycoses, Coccidioides immitis Infection, Coccidioides posadasii Infection, Infections, Invasive Fungal Infections, coccidioidomycosis, fungal infectious disease | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07712484 | |
| Pacritinib Effectiveness in Real-world Settings | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Not stated | 2026-09-14 | NCT07774455 | |
| Safety and Efficacy of J147 in Acute Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 | 2026-08-24 | NCT07430917 | |
| Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis | Drug Susceptible Pulmonary Tuberculosis | Recruiting | Phase 2 | 2026-07-30 | NCT07525427 | |
| Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. | Deglutition Disorders, Digestive System Diseases, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease | Active, not recruiting | Phase 3 | 2026-07-27 | NCT05267613 |